MARCHESE, PAOLA VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 101
EU - Europa 82
AS - Asia 73
AF - Africa 15
OC - Oceania 3
Totale 274
Nazione #
US - Stati Uniti d'America 101
SG - Singapore 37
IT - Italia 36
CN - Cina 18
IE - Irlanda 10
IN - India 10
SE - Svezia 9
CI - Costa d'Avorio 7
DE - Germania 6
JO - Giordania 6
CH - Svizzera 5
TG - Togo 5
BG - Bulgaria 4
FI - Finlandia 4
AU - Australia 3
GB - Regno Unito 3
NG - Nigeria 2
NL - Olanda 2
AT - Austria 1
BD - Bangladesh 1
BE - Belgio 1
RU - Federazione Russa 1
SN - Senegal 1
VN - Vietnam 1
Totale 274
Città #
Singapore 33
Ashburn 14
Chandler 13
Dublin 10
Hyderabad 9
Abidjan 7
Bologna 7
Amman 6
Santa Clara 6
Lomé 5
Bern 4
New York 4
Princeton 4
Rimini 4
Sofia 4
Beijing 3
Helsinki 3
Abeokuta 2
Bari 2
Berlin 2
Borgomanero 2
Bremen 2
Enschede 2
Ferrara 2
Melbourne 2
Milan 2
Palermo 2
Seattle 2
Southend 2
Turin 2
Verona 2
Woodbridge 2
Boydton 1
Brussels 1
Canberra 1
Chicago 1
Fairfield 1
Florence 1
Forlì 1
Hanoi 1
Harbin 1
Jinan 1
Lappeenranta 1
Los Angeles 1
Lugano 1
Mülheim 1
Nanjing 1
Olalla 1
Prescot 1
Qingdao 1
Rajshahi 1
Shenzhen 1
Trento 1
Vienna 1
Totale 188
Nome #
Baseline total metabolic tumour volume on 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography-computed tomography as a promising biomarker in patients with advanced non-small cell lung cancer treated with first-line pembrolizumab. 55
Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges 51
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC 45
A hypothesis-generating analysis on the role of TERT promoter mutation in advanced urothelial carcinoma treated with immunotherapy 34
Lymph node ratio predicts efficacy of postoperative radiation therapy in nonmetastatic Merkel cell carcinoma: A population-based analysis 28
Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers 23
Agnostic Approvals in Oncology: Getting the Right Drug to the Right Patient with the Right Genomics 20
TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab 19
Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review 14
Development and validation of a new tool to estimate early mortality in patients with advanced cancer treated with immunotherapy 3
Totale 292
Categoria #
all - tutte 1.503
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.503


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202220 0 0 0 0 0 0 0 7 0 0 6 7
2022/2023130 7 11 2 4 16 9 7 10 32 4 12 16
2023/202456 6 8 3 4 2 20 0 3 1 2 7 0
2024/202586 29 37 15 5 0 0 0 0 0 0 0 0
Totale 292